Enhabit (NYSE:EHAB) Updates FY 2025 Earnings Guidance

Enhabit (NYSE:EHAB) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.500-0.560 for the period, compared to the consensus estimate of 0.490. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Enhabit Trading Up 3.2%

Shares of Enhabit stock traded up $0.25 on Friday, reaching $7.96. 528,536 shares of the company’s stock were exchanged, compared to its average volume of 432,115. The company has a market capitalization of $403.24 million, a P/E ratio of -31.82 and a beta of 1.69. Enhabit has a 52 week low of $6.47 and a 52 week high of $10.90. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.57 and a current ratio of 1.57. The firm’s 50-day moving average is $8.08 and its two-hundred day moving average is $8.37.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.05. The company had revenue of $263.60 million during the quarter, compared to analyst estimates of $267.08 million. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.96%. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Sell-side analysts predict that Enhabit will post 0.22 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on EHAB shares. UBS Group lowered their price objective on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating on the stock in a report on Friday, August 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Enhabit in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $8.67.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets raised its stake in Enhabit by 11.0% in the second quarter. BNP Paribas Financial Markets now owns 23,742 shares of the company’s stock worth $229,000 after buying an additional 2,350 shares in the last quarter. WINTON GROUP Ltd purchased a new position in shares of Enhabit during the 2nd quarter worth approximately $212,000. Brown Advisory Inc. bought a new position in shares of Enhabit in the 2nd quarter worth approximately $287,000. New York State Common Retirement Fund raised its position in shares of Enhabit by 853.4% in the 2nd quarter. New York State Common Retirement Fund now owns 55,535 shares of the company’s stock worth $535,000 after acquiring an additional 49,710 shares in the last quarter. Finally, Prudential Financial Inc. lifted its stake in shares of Enhabit by 139.8% in the 2nd quarter. Prudential Financial Inc. now owns 31,894 shares of the company’s stock valued at $307,000 after purchasing an additional 18,595 shares during the period.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.